Publications for Aril Frydén
Co-author map based on ISI articles 2007-
Journal Articles
Christoffer Sjöwall, Kristina Cardell, Maria I Bokarewa, Helena Enocsson, Mattias Ekstedt, Liselott Lindvall, Aril Frydén and Sven Almer
High prevalence of autoantibodies to C-reactive protein in patients with chronic hepatitis C infection: association with liver fibrosis and portal inflammation
Human Immunology, 2012, 73(4), 382-388.
Fulltext  |
Einar Bjornsson, Hans Verbaan, Antti Oksanen, Aril Frydén, Jonas Johansson, Sarah Friberg, Olav Dalgard and Evangelos Kalaitzakis
Health-related quality of life in patients with different stages of liver disease induced by hepatitis C
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2009, 44(7), 878-887.
Web of Science® Times Cited: 7 |
Olav Dalgard, Kristian Bjøro, Helmer Ring-Larsen, Einar Bjornsson, Mona Holberg-Petersen, Eva Skovlund, Olle Reichard, Bjørn Myrvang, Bo Sundelöf, Ståle Ritland, Kjell Hellum, Aril Frydén, Jon Florholmen and Hans Verbaan
Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response
Hepatology, 2008, 47(1), 35-42.
Web of Science® Times Cited: 116 |
Kristina Cardell, A Widell, Aril Frydén, Britt Åkerlind, A-S Månsson, Stefan FranzÉn, U-B Lymer and Barbro Isaksson
Nosocomial hepatitis C in a thoracic surgery unit, retrospective findings generating a prospective study
Journal of Hospital Infection, 2008, 68(4), 322-328.
Web of Science® Times Cited: 3 |
Kristina Cardell, Britt Åkerlind, Matti Sällberg and Aril Frydén
Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine
Journal of Infectious Diseases, 2008, 198(3), 299-304.
Web of Science® Times Cited: 26 |
I. Uhnoo, A. Linde, K. Pauksens, A. Lindberg, M. Eriksson, R. Norrby, B. Beermann, C. Brandt, Aril Frydén, L. Gothefors, J. Hakansson, B. Claesson, K. Nivenius, C. Petersson, A. Schwan, L. Stahle, I. Trolin and Wirgart B. Zweygberg
Treatment and prevention of influenza: Swedish recommendations
Scandinavian Journal of Infectious Diseases, 2003, 35(1), .
|
Fariba Nayeri, I. Nilsson, Lars Brudin, Aril Frydén and C. Söderström
High serum hepatocyte growth factor levels in the acute stage of community-acquired infectious diseases
Scandinavian Journal of Infectious Diseases, 2002, 34(2), 127-130.
Web of Science® Times Cited: 12 |
Fariba Nayeri, Lars Brudin, Johan Darelid, Ingela Nilsson, Aril Frydén, Claes Söderström and Pia Forsberg
Hepatocyte growth factor may act as an early therapeutic predictor in pneumonia
Scandinavian Journal of Infectious Diseases, 2002, 34(7), 500-504.
Web of Science® Times Cited: 5 |
UL Mathiesen, LE Franzén, H Åselius, M Resjö, L Jacobsson, U Foberg, Aril Frydén and Göran Bodemar
Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases
Digestive and Liver Disease, 2002, 34(7), 516-522.
Web of Science® Times Cited: 88 |
K Hedin, Ankica Babic and Aril Frydén
Liver guide for monitoring of chronic hepatitis C
JAMIA Journal of the American Medical Informatics Association, 2000, , 340-343.
|
O Reichard, H Glaumann, Aril Frydén, G Norkrans, R Wejstål and O Weiland
Long term follow-up of chronic hepatitis C patients with sustained virological response to alfa-interferon.
Journal of Hepatology, 1999, 30, 783-787.
|
O Weiland, JH Braconier, Aril Frydén, G Norkrans, O Reichard and I Uhnoo
Influence of pre-treatment factors on outcome of interferon-alpha treatment of patients with chronic hepatitis C.
Scandinavian Journal of Infectious Diseases, 1999, 31, 115-118.
|
UL Mathiesen, LE Franzén, Aril Frydén, U Foberg and Göran Bodemar
The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients.
Scandinavian Journal of Gastroenterology, 1999, 34, 85-91.
|
Kristina Cardell, Aril Frydén and Bengt Normann
Intradermal hepatitis B vaccination in health care workers. Response rate and experiences from vaccination in clinical practise
Scandinavian Journal of Infectious Diseases, 1999, 31(2), 197-200.
|
Chapters in Books
Conference Articles
Magnus Hedenstierna, Ingrid Uhnoo, Soo Aleman, Aril Frydén, Gunnar P Norkrans, Anders Eilard, Hans Glaumann and Ola Weiland
DURABILITY OF SVR AND FIBROSIS IMPROVEMENT AFTER SOC TREATMENT FOR CHRONIC HCV-10 YEARS FOLLOW-UP in HEPATOLOGY, vol 54, issue , pp 839A-840A
HEPATOLOGY vol 54, 2011.
|
K Hedin, Ankica Babic and Aril Frydén
Take care: Patient oriented information system regarding chronic hepatitis C
JAMIA Journal of the American Medical Informatics Association, 1999.
|
Kristina Hedin, Ankica Babic and Aril Frydén
Take CAre: Patient-orientedinformation system regarding chronic hepatitis C
Medical Informatics Europe99,1999, 1999.
|
Kristina Hedin, Ankica Babic and Aril Frydén
Take care: Guidelines for patients with chronic Hepatitis C
Medical Informatics Europe99,1999, 1999.
|
Ankica Babic, Kristina Hedin, Ulrik Mathiesen, Lennart Franzén, Aril Frydén, Göran Bodemar and Ove Wigertz
Decision support for monitoring of chronic Hepatitis C: can blood laboratory tests help?
Medical Informatics Europe 96,1996, 1996.
|
Ulrik Mathiesen, Ewa Krusinska, Göran Bodemar, Shamsul Chowdhury, Ankica Babic, Lennart Franzén, Aril Frydén and Ove Wigertz
Investigation and follow-up of patients with raised levels of liver transaminases. Computerised support for high quality and cost-effetiveness
Medical Informatics in Europe MIE94,1994, 1994.
|
Ewa Krusinska, Ankica Babic, Ulrik Mathiesen, Lennart Franzén, Ulla Foberg, Aril Frydén, Göran Bodemar and Ove Wigertz
Empirical modelling versus commonly applied data analysis techniques as used for decision support in liver diseases
MEDINFO92,1992, 1992.
|
Ph.D. Theses
Ph.D., Lic. Theses
